LD Micro Main Event
December 10-12, 2019
Luxe Hotel Sunset Boulevard (Los Angeles)
Taking place in Bel Air, California, LD Micro's 12th annual Main Event conference is a collection of more than 275 companies from all around the globe, representing all industries. It is the only conference where the most influential names of the buy-side and sell-side gather to collaborate, research and invest. For more information on LD Micro, visit www.ldmicro.com
22nd Century Group Inc. (XXII)
22nd Century (NYSE: XXII) is a plant biotechnology company aimed at reducing the harm caused by smoking. The company's long-term focus is the research, development, licensing, manufacturing and worldwide sales and distribution of our important products. As a result of 22nd Century's unique technology, the company is able to grow tobacco with up to 97% less nicotine than conventional tobacco – as well as plants with relatively high nicotine levels. The applications for this technology are extraordinary. For more information, visit the company's website at www.xxiicentury.com.
Abacus Health Products Inc. (ABAHF)
Abacus Health Products (OTCQX: ABAHF) was formed with the mission to deliver pain relief and skincare products by developing advanced topical formulas that combine CBD hemp extract and oil from the cannabis sativa L. plant with active pharmaceutical ingredients (APIs). Aidance Scientific launched Abacus in 2014 as a leader in the market. The company is the first to develop a family of OTC products that are blended with CBD hemp extract (cannabis sativa L.). Abacus expanded its product line in 2019 to include a full range of pain relief products as well as a new skincare line. For more information, visit the company's website at www.abacushp.com.
Acerus Pharmaceuticals (TSX: ASP) (OTCQB: ASPCF) is focused on the commercialization and development of innovative pharmaceutical products that improve the patient experience. Founded in 2008, Acerus has grown into a fully integrated, specialty pharmaceutical company with expertise in all stages of the pharmaceutical product life-cycle. The company is focused on men's health (urology and andrology). The company's foundational product is NATESTO®, a testosterone therapy based on patented nasal gel technology, approved in the United States, Canada and South Korea for the treatment of adult males diagnosed with hypogonadism. For more information, visit the company's website at www.aceruspharma.com.
Acme United Corp. (ACU)
For the past 150 years, Acme United (NYSE: ACU) has been a leading worldwide supplier of innovative cutting, measuring, first aid and sharpening products to the school, home, office, hardware, sporting goods and industrial markets. The company operations reside in the United States, Canada, Europe (located in Germany) and Asia (located in Hong Kong and China). Acme United's brands include First Aid Only®, PhysiciansCare®, Pac-Kit®,Spill Magic®, Westcott®, Clauss®, Camillus®, Cuda®, and DMT®. For more information, visit the company's website at www.acmeunited.com.
AgEagle Aerial Systems Inc. (UAVS)
Since its founding in 2010, AgEagle Aerial Systems (NYSE: UAVS) has grown to become a trusted partner to major food manufacturers and precision farmers seeking to adopt and support productive agricultural approaches to better farming practices which limit impact on our natural resources, reduce reliance on inputs, and materially increase crop yields and profits. AgEagle was created to pioneer, innovate and advance aerial imaging data collection and analytics technologies capable of addressing the impending food and environmental sustainability crises that threaten our planet. The company's daily efforts are focused on delivering the metrics, tools and strategies necessary to define and implement intelligent sustainability and precision farming solutions that solve important problems. For more information, visit the company's website at www.ageagle.com.
Air Industries Group Inc. (AIRI)
Air Industries Group (NYSE: AIRI) is an aerospace and defense company that has been supplying flight critical and other sophisticated parts and assemblies to prime defense and commercial aerospace manufacturers for over 40 years. The company designs and manufactures structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls and throttle quadrants. The company also provides sheet metal fabrication for aerostructures, tube bending and welding services. For more information, visit the company's website at www.airindustriesgroup.com.
Algernon Pharmaceuticals (CSE: AGN) (FRANKFURT: AGW) (OTCQB: BTHCF) is a clinical stage drug development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF). The Algernon drug development program offers an innovative approach to drug discovery that was developed over many years by company CSO Dr. Mark Williams, a senior scientist in the drug development industry. Algernon's unique approach to drug discovery is based on the concept of drug repurposing. Drug repurposing is the process of discovering new therapeutic uses for existing drugs. Repurposing offers several benefits over traditional drug development including a reduction in investment and risk, shorter research periods and a longer active patent life. For more information, visit the company's website at www.algernonpharmaceuticals.com.
Alimera Sciences, Inc. (ALIM)
Alimera Sciences (NASDAQ: ALIM) is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. The company presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera Sciences' management team are dedicated and focused to making Alimera a leading ophthalmic pharmaceutical company. Alimera's team has demonstrated expertise through the extensive commercialization and development of ophthalmic products. For more information, visit the company's website at www.alimerasciences.com.
Allot Ltd. (ALLT)
Allot (NASDAQ: ALLT) is a leading provider of innovative network intelligence and security solutions that empower communications service providers (CSPs) and enterprises worldwide to enhance the value they bring to customers. With more than 20 years of proven success, Allot's solutions turn network, application, usage and security data into actionable intelligence that make customers' networks smarter and their users more secure. The company's network-based security platform disrupts the security industry by positioning CSPs as leading Security-as-a-Service providers with market penetration exceeding 50% and protecting over 20 million subscribers worldwide. For more information, visit the company's website at www.allot.com.
Alpine 4 Technologies Ltd. (ALPP)
Alpine 4 Technologies (OTC: ALPP) is a publicly traded enterprise with business related endeavors in software, automotive technologies, electronics manufacturing, and energy services and fabrication technologies. Alpine 4's acquisition model is industry agnostic and is based around its "Driver, Stabilizer, Facilitator" business model. Four principles at the core of the company's business are: synergy, innovation, drive and excellence. At Alpine 4, synergistic innovation drives excellence. By anchoring these words to its combined experience and capabilities, the company is able to aggressively pursue opportunities within and across vertical markets. For more information, visit the company's website at www.alpine4.com.
Alternus Energy Inc. (ALTN)
Alternus Energy (OTC: ALTN) is a global independent power producer ("IPP") that develops, owns and operates solar PV parks that connect directly to national power grids. The company's current revenue streams are generated from long-term, government-mandated, fixed-price supply contracts with terms of between 15-20 years in the form of government Feed-In-Tariffs ("FiT") and other energy incentives. In general, these contracts generate an average sales rate for every kWh of green energy produced by our solar parks. Alternus Energy's current focus is on the European solar PV market. The company is also actively exploring opportunities in other countries outside of Europe. For more information, visit the company's website at www.alternusenergy.com.
Amarantus Bioscience Holdings Inc. (AMBS)
Amarantus Bioscience (OTC: AMBS) is a JLABS alumnus biotechnology company developing treatments and diagnostics for diseases in the areas of neurology, regenerative medicine and orphan diseases. The company's lead therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia, one of the most difficult problems facing patients with Parkinson's disease. Eltoprazine is currently in a Phase 2b clinical trial with results from the study expected in 2016. Eltoprazine is also being evaluated for the treatment of adult attention deficit hyperactivity disorder (ADHD) and Alzheimer's aggression. For more information, visit the company's website at www.amarantus.com.
Amazing Energy Oil and Gas Co. (AMAZ)
Amazing Energy Oil and Gas (OTCQX: AMAZ) is an independent oil and gas exploration and production company headquartered in Plano, Texas. The company's primary leaseholds are in the Permian Basin with rights within a 70,000-acre leasehold in Pecos County, Texas, and approximately 5,385 gross acreage in Lea County, New Mexico. The company primarily engages in the exploration, development, production and acquisition of oil and natural gas properties. For more information, visit the company's website at www.amazingenergy.com.
AmeraMex International Inc. (AMMX)
AmeraMex International (OCTQB: AMMX) sells, leases and rents heavy equipment to companies within multiple industries including construction, logistics, mining, and lumber. The company has more than 30 years of experience in heavy equipment sales and service. Since its 1990 incorporation, the company has grown to become a provider of new and refurbished heavy equipment to logistics companies, infrastructure construction, logging companies, U.S. military and forestry conservation organizations—both nationally and internationally. AmeraMex International began trading on the OCTQB July 2019. For more information, visit the company's website at www.ammx.net.
American Battery Metals Corp. (ABML)
American Battery Metal (OTCQB: ABML) is a start-up lithium exploration mining company whose purpose is to explore mineral properties that may contain lithium and other economic minerals. American Battery Metals currently has mining claims on 26,000 acres in the area known as the Western Nevada Basin, situated in Railroad Valley in Nye County, Nevada (the "WNB Claim"). The company's board of directors is currently guiding American Battery through a significant management reorganization and to reorient the company's goals and objective to solely focus on the exploration and development of lithium and other battery metal deposits in the State of Nevada, primarily through new capital commitments which Mr. Cole is actively seeking. For more information, visit the company's website at www.batterymetals.com.
American Pacific Mining (CSE: USGD) (OTC: USGDF) (FWB: 1QC) ("APM") is a gold exploration company, eyeing a gold discovery in the Western USA. The company is focused on building and drilling a portfolio of precious metal projects. APM's team believes there is a golden opportunity to discover and explore precious metal assets in historically productive districts, alongside the next bull market in commodities. Discover and add value – those steps summarize what this company aims to accomplish. For more information, visit the company's website at www.americanpacific.ca.
American Shared Hospital Services (AMS)
American Shared Hospital Services (NYSE: AMS) is a healthcare company with more than a 30-year track record of leasing state-of-the-art medical equipment to hospitals and medical centers in the United States and abroad. The company provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is the world leader in providing Gamma Knife radiosurgery equipment, a non‑invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The company also offers proton therapy, and the latest IGRT and IMRT systems. For more information, visit the company's website at www.ashs.com.
Antibe Therapeutics (TSXV: ATE) (OTCQB: ATBPF) is a public biotech company with a drug platform of game-changing therapeutics in pain and inflammation. Its lead drug, ATB-346, recently showed unequivocal superiority to naproxen in GI safety. The company's combined pipeline is targeting a global market opportunity in excess of $20 billion. Antibe's commercial division in regenerative medicine is on a growth trajectory in the dental biologics market. Antibe is pursuing a major advance in the safe and non-addictive treatment of pain and inflammation. Antibe's subsidiary, Citagenix Inc., is a leader in the sales and marketing of tissue regenerative products for oral and maxillofacial surgery. For more information, visit the company's website at www.antibethera.com.
Apollo Endosurgery Inc. (APEN)
Apollo Endosurgery (NASDAQ: APEN) is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 70 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon. For more information, visit the company's website at www.apolloendo.com.
Applied BioSciences Corp. (APPB)
Applied BioSciences (OTCQB: APPB) is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics, or biopharmaceuticals, that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company delivers high-quality consumer and over-the-counter THC-free CBD products that promote overall health and wellbeing, as well as state-of-the-art testing and analytics capabilities to customers. For more information, visit the company's website at www.appliedbiocorp.com.
Arch Therapeutics Inc. (ARTH)
Arch Therapeutics (OTCQB: ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's development-stage product candidates include the AC5™ Topical Gel and the AC5™ Surgical Hemostatic Device. For more information, visit the company's website at www.archtherapeutics.com.
Arcimoto Inc. (FUV)
Arcimoto (NASDAQ: FUV) is devising new technologies and patterns of mobility that together raise the bar for environmental efficiency, footprint and affordability. Available for pre-order today, Arcimoto's Fun Utility Vehicle ("FUV"), Rapid Responder, and Deliverator are some of the lightest, most affordable, and most appropriate electric vehicles suitable for everyday transport. Arcimoto has demonstrated that the FUV meets the performance requirements of the Federal Motor Vehicle Safety Standards for a motorcycle. The FUV front face features impact energy absorption zones, and FUV seating includes a standard 3-point safety belt paired with a second 3-point belt over the opposing shoulder. For more information, visit the company's website at www.arcimoto.com.
Arcturus Therapeutics Inc. (ARCT)
Arcturus Therapeutics Holdings (NASDAQ: ARCT) is an RNA medicines company with enabling technologies – LUNAR® lipid-mediated delivery, Unlocked Nucleomonomer Analog (UNA) chemistry, STARR technology™ – and mRNA drug substance along with drug product manufacturing. The company's diverse pipeline of RNA therapeutics includes programs to potentially treat Ornithine Transcarbamylase (OTC) deficiency, cystic fibrosis, glycogen storage disease Type 3, Hepatitis B, and non-alcoholic steatohepatitis (NASH). Arcturus' versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines. Arcturus' technologies are covered by its extensive patent portfolio (177 patents and patent applications, issued in the U.S., Europe, Japan, China and other countries). For more information, visit the company's website at www.arcturusrx.com.
Artelo Biosciences Inc. (ARTL)
Artelo Biosciences (NASDAQ: ARTL) is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. The company's programs have the potential to dramatically improve patient care in major markets. Artelo's science-based approach rests on three pillars that uniquely position the company for growth: an unwavering dedication to letting the science lead; a portfolio-based, de-risked and nimble business strategy; and an experienced leadership team with proven performance in regulated drug development and global commercialization. For more information, visit the company's website at www.artelobio.com.
Assure Holdings (TSXV: IOM) (OTCQB: ARHH) works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists, uses its own state-of-the-art monitoring equipment, and handles 100% of intraoperative neuromonitoring scheduling and setup, as well as bills for all technical services provided. While Assure focuses primarily on supporting spinal and vascular surgeries, plans are in place to support other classes of medicine that rely on the standard of care that intraoperative neuromonitoring provides. Assure is recognized as providing the highest level of patient care in the industry and has earned the Joint Commission's Gold Seal of Approval®. For more information, visit the company's website at www.assureneuromonitoring.com.
AstroNova Inc. (ALOT)
AstroNova® (NASDAQ: ALOT) is a global leader in developing and applying data visualization technologies in products serving industrial, packaging, aerospace and defense markets. The company delivers total solutions that acquire, process, analyze, store, print and present data in a variety of useable forms. These solutions are adapted specifically to customer requirements to enhance the quality, productivity and profitability of their businesses. Innovation, coupled with exceptional responsiveness and technical support, creates the competitive edge that makes AstroNova the world leader in all of its markets. For more information, visit the company's website at www.astronovainc.com.
Atossa Genetics (ATOS)
Atossa Genetics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. The company's innovative therapies and delivery methods can transform breast cancer treatment – with the goals of preventing breast cancer from developing in the first place, to increasing the odds of surviving for those who do develop this deadly disease. Approximately one in eight women and one in 1,000 men will be diagnosed with breast cancer during their lifetime. For more information, visit the company's website at www.atossagenetics.com.
Avalon GloboCare Corp. (AVCO)
Avalon GloboCare (NASDAQ: AVCO) is a global intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology and their clinical applications, as well as healthcare facility management through its core platforms, "Avalon Cell" and "Avalon Rehab." In addition, Avalon provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth, development, as well as competitiveness in both domestic and global healthcare markets. Avalon, via its subsidiary "Avalon RT9 Properties LLC,"also engages in the acquirement and management of healthcare facility. For more information, visit the company's website at www.avalon-globocare.com.
Aytu BioScience Inc. (AYTU)
Aytu BioScience (NASDAQ: AYTU) is committed to better health for men, women, and children here at home and worldwide. An emerging specialty pharmaceutical company, Atyu is focused on commercializing novel products that address significant patient needs. The company is dedicated to better health and better living for patients. By acquiring or licensing approved, commercialized products and late-stage development therapeutics, we bring novel and needed treatments to market and to the millions of patients that need them. Novel products that can really help people feel better—and these products can make an impact today on patients' health and well-being. For more information, visit the company's website at www.aytubio.com.
Barfresh Food Group Inc. (BRFH)
Barfresh Food Group (OTCQB: BRFH) is a developer, manufacturer and distributor of ready-to-blend beverages, including smoothies, shakes and frappes, primarily for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, better for you and without waste. Barfresh has an exclusive distribution partnership with the leading food distributor in North America. For more information, visit the company's website at www.barfresh.com.
Bel Fuse (NASDAQ: BELFA) (NASDAQ: BELFB) manufactures and markets a broad array of products that power, protect and connect electronic circuits. These products are primarily used in the networking, telecommunications, computing, military, aerospace, transportation and broadcasting industries. Bel's product groups include Magnetic Solutions (integrated connector modules, power transformers, power inductors and discrete components), Power Solutions and Protection (front-end, board-mount and industrial power products, module products and circuit protection), and Connectivity Solutions (expanded beam fiber optic, copper-based, RF and RJ connectors and cable assemblies). The company operates facilities around the world. For more information, visit the company's website at www.belfuse.com.
Biocept Inc. (BIOC)
Biocept (NASDAQ: BIOC) is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The company leverages its proprietary liquid biopsy technology to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with cancer. Biocept's patented Target Selector™ liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and in circulating tumor DNA (ctDNA). With thousands of tests performed, the platform has demonstrated the ability to identify cancer mutations and alterations to inform physicians about a patient's disease and therapeutic options. For more information, visit the company's website at www.biocept.com.
BioCorRx Inc. (BICX)
BioCorRx (OTC: BICX) offers a unique multi-component approach to the treatment of substance abuse addiction. The BioCorRx® Recovery Program is a non-addictive, medication-assisted treatment (MAT) program. The first component consists of an outpatient implant procedure performed by a licensed physician. The implant delivers the non-addictive medicine naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids. The second component of the program is a one-on-one proprietary counseling program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. For more information, visit the company's website at www.biocorrx.com.
Biofrontera AG (BFRA)
Biofrontera (NASDAQ: BFRA) is a biopharmaceutical company specializing in the development and sale of dermatological drugs and medical cosmetics. The Germany-based company, with almost 200 employees worldwide, develops and markets innovative products for the care, protection and treatment of the skin. The company's lead product is the combination of Ameluz®, a topical prescription drug, and medical device BF-RhodoLED® for the photodynamic therapy of certain superficial skin cancers and their precursors. For more information, visit the company's website at www.biofrontera.com/en.
BioLargo Inc. (BLGO)
BioLargo (OTCQB: BLGO) invents, patents and develops innovative platform technologies for three markets: advanced water and wastewater treatment, industrial odor and VOC control, and advanced wound care products. With a wide array of issued patents, an extensive R&D talent pool, and a full-service engineering team, the company maintains a robust pipeline of products from inception through maturity. BioLargo monetizes its technology assets with the goal of maximizing both impact and shareholder value, using licensing, strategic partnership, and direct-to-market strategies. For more information, visit the company's website at www.biolargo.com.
BIOLASE Inc. (BIOL)
BIOLASE (NASDAQ: BIOL) is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed to provide clinically superior, patient friendly results for many types of common dental procedures compared to those achieved with traditional instruments. BIOLASE has sold over 36,200 laser systems to date in over 90 countries around the world. For more information, visit the company's website at www.biolase.com.
Biomerica Inc. (BMRA)
Biomerica (NASDAQ: BMRA) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. The company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica primarily focuses on products for gastrointestinal disease, diabetes and esoteric testing. For more information, visit the company's website at www.biomerica.com.
Boxlight Corp. (BOXL)
Boxlight (NASDAQ: BOXL) provides technology and STEM solutions for the global education market. The company improves student engagement and learning outcomes by providing educators the products they need for the 21st Century classroom. The company develops, sells and services its integrated, interactive solution suite of software, classroom technologies, professional development, and support services. Boxlight also provides educators with thousands of free lesson plans and activities via MimioConnect®, an interactive teaching community. For more information, visit the company's website at www.boxlight.com.
Broadwind Energy Inc. (BWEN)
Broadwind (NASDAQ: BWEN) is a precision manufacturer of structures, equipment and components for clean tech and other specialized applications. From gears and gearing systems for wind, oil and gas and mining applications, to wind towers and industrial weldments, the company has solutions for the clean tech, energy and infrastructure needs of the future. With facilities throughout the U.S., Broadwind's team is committed to helping customers maximize performance of their investments—quicker, easier and smarter. For more information, visit the company's website at www.bwen.com.
Burcon Nutrascience (BUROF)
Burcon NutraScience (OTC: BUROF) is a world leader in innovative technologies for the large-scale production of high-quality, cost-effective plant-based proteins and ingredients for use in the global food and beverage industries. Building on the company's unique environmentally friendly and clean-label extraction and purification technologies, the Burcon NutraScience boasts an extensive portfolio of innovative composition, application, and process patents. The company's proprietary processes are clean and cost-effective resulting in highest-quality plant-based proteins. For more information, visit the company's website at www.burcon.ca.
Calyxt Inc. (CLXT)
Calyxt (NASDAQ: CLXT) is a plant-based technology company that utilizes patented breeding technology to make foods that offer a healthier choice. The company takes care that extends beyond nutritional value. Calyxt has partnered with farmers and food companies to deliver traceable plant-based products developed to be healthier and more sustainable than their conventional counterparts. The company uses cutting-edge plant breeding techniques to develop products that help improve diets by reducing bad fats, allergens and toxins. Calyxt continuously pursues innovation to deliver good food that is good for consumers. For more information, visit the company's website at www.calyxt.com.
Canbiola Inc. (CANB)
Canbiola (OTCQB: CANB) is a vertically integrated conglomerate specializing in the manufacturing, formulation and sale of THC-free cannabidiol (CBD) isolate products such as oils, drops/tinctures, gels, creams, moisturizers, chews and capsules. All Canbiola products are organic and non-GMO, free of impurities and contaminants, and formulated with the finest ingredients to the highest manufacturing standards. All products are certified for purity and accuracy by third-party laboratory verification. Canbiola pursues an aggressive growth strategy through the continual development of proprietary products and the expansion of its offerings via strategic acquisitions in the healthcare and CBD industries. For more information, visit the company's website at www.canbiola.com.
Capstone Turbine Corp. (CPST)
Capstone Turbine (NASDAQ: CPST) produces highly efficient, low-emission, resilient microturbine energy systems. Capstone microturbines serve multiple vertical markets worldwide, including natural resources, energy efficiency, renewable energy, critical power supply, transportation and microgrids. Capstone offers a comprehensive product lineup, providing scalable systems focusing on 30 kWs to 10 MWs that operate on a variety of gaseous or liquid fuels and are the ideal solution for today's distributed power generation needs. To date, Capstone has shipped over 9,000 units to 73 countries and have saved customers an estimated $253 million in annual energy costs and 350,000 tons of carbon. For more information, visit the company's website at www.capstoneturbine.com.
Carriage Services Inc. (CSV)
Carriage Services (NYSE: CSV) is a provider of professional funeral and cemetery services and products in the United States. Carriage Services is committed to being the most professional, ethical, and highest quality organization in the industry. The company strives to show that the right quality of staff provides the necessary foundation to fuel its high-performance culture as it strives be the best at serving the needs of client families and communities nationwide. For more information, visit the company's website at www.carriageservices.com.
Ceapro Inc. (CRPOF)
Ceapro (OTCQX: CRPOF) is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and "active ingredients" from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information, visit the company's website at www.ceapro.com.
CEL-SCI Corp. (CVM)
CEL-SCI (NYSE: CVM) believes that boosting a patient's immune system while it is still intact should provide the greatest possible impact on survival. Therefore, in a Phase 3 study, CEL-SCI treats patients who are newly diagnosed with advanced primary squamous cell carcinoma of the head and neck with the investigational product Multikine first, BEFORE they receive surgery, radiation and/or chemotherapy. CEL-SCI believes that this Phase 3 study is the largest Phase 3 study in the world for the treatment of head and neck cancer. The Phase 3 study is fully enrolled with 928 patients and the last patient was treated in September 2016. The company's experimental LEAPS technology is currently being developed as a potential therapeutic vaccine for rheumatoid arthritis and is supported by grants from the National Institutes of Health. CEL-SCI has operations in Vienna, Virginia and near Baltimore, Maryland. For more information, visit the company's website at www.cel-sci.com.
Champions Oncology Inc. (CSBR)
Champions Oncology (NASDAQ: CSBR) is a global contract research organization that provides end-to-end R&D solutions and services, ranging from in vitro cell line assessments, modeling treatment in the clinic using highly predictive PDX models, as well as assessing clinical patient samples by high dimensional flow cytometry techniques. Champions Oncology is actively engaged in the development of advanced technology solutions and services to improve the development and use of oncology therapeutics. For more information, visit the company's website at www.championsoncology.com.
Chicken Soup for the Soul Entertainment Inc. (CSSE)
Chicken Soup for the Soul Entertainment (NASDAQ: CSSE) is a growing media company building and acquiring streaming video-on-demand networks (VOD) that provide content for all screens. The company owns a majority stake in Crackle Plus, a joint venture with Sony Pictures Television, which owns and operates a variety of ad-supported and subscription-based VOD networks including Crackle, Popcornflix, Popcornflix Kids, Truli, Pivotshare, Españolflix and FrightPix. The company also acquires and distributes video content through its Screen Media subsidiary and produces long and short-form original content through Landmark Studio Group, its Chicken Soup for the Soul Originals division and through APlus.com. Chicken Soup for the Soul Entertainment is a subsidiary of Chicken Soup for the Soul, LLC, which publishes the famous book series and produces super-premium pet food under the Chicken Soup for the Soul brand name. For more information, visit the company's website at www.cssentertainment.com.
Cinedigm Corp. (CIDM)
Cinedigm (NASDAQ: CIDM) powers custom content solutions to the world's largest retail, media and technology companies. The global company provides premium feature films and series to digital platforms including Netflix, Amazon, Xumo, Roku, Vizio, Dish/Sling, Apple, and Google plus cable/satellite providers including Comcast, Dish Network and DirectTV in addition to major retailers including Wal-Mart and Target. Leveraging Cinedigm's unique capabilities, content and technology, the company has emerged as a leader in the fast-growing digital-first channel business, with seven networks under management that reach hundreds of millions of devices while also providing premium content and service expertise to the entire digital-first ecosystem. With reciprocal distribution partnerships in both the United States and China, Cinedigm's growing stable of platforms has unprecedented availability in the two largest markets in the world. For more information, visit the company's website at www.cinedigm.com.
Citius Pharmaceuticals Inc. (CTXR)
Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives, cancer care, and unique prescription products that use innovative, patented, or proprietary formulations of previously approved active pharmaceutical ingredients. The company seeks to achieve leading market positions by providing therapeutic products that address unmet medical needs. By using previously approved drugs with substantial safety and efficacy data, Citius seeks to reduce the risks associated with pharmaceutical product development and regulatory requirements. Citius develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches. For more information, visit the company's website at www.citiuspharma.com.
CleanSpark Inc. (CLSK)
CleanSpark (OTCQB: CLSK) provides advanced energy software and control technology that enables a plug-and-play enterprise solution to modern energy challenges. The company's services consist of intelligent energy monitoring and controls, microgrid design and engineering, microgrid consulting services and turn-key microgrid implementation services. CleanSpark's software allows energy users to obtain resiliency and economic optimization. Its software is uniquely capable of enabling a microgrid to be scaled to the user's specific needs and can be widely implemented across commercial, industrial, military, agricultural and municipal deployment. For more information, visit the company's website at www.cleanspark.com.
CLPS Inc. (CLPS)
CLPS (NASDAQ: CLPS) is a global information technology ("IT"), consulting and solutions service provider focused on the banking, insurance and financial sectors. The company serves as an IT solutions provider to a growing network of clients in the global financial industry, including large financial institutions in the U.S., Europe, Australia and Hong Kong and their PRC-based IT centers. CLPS maintains ten delivery and/or research and development centers to serve different customers in various geographic locations. Mainland China centers are located in Shanghai, Beijing, Dalian, Tianjin, Chengdu, Guangzhou and Shenzhen. The remaining three global centers are located in Hong Kong, Singapore and Australia. For more information, visit the company's website at www.clpsglobal.com.
CNS Pharmaceuticals Inc. (CNSP)
CNS Pharmaceuticals (NASDAQ: CNSP) is a biotechnology company specializing in the development of novel treatments for primary and metastatic brain and central nervous system tumors. Its lead candidate Berubicin is for the treatment of glioblastoma, a type of brain cancer currently considered incurable, as well as pancreatic and ovarian cancers, and lymphomas. The company entered into an IP agreement with Houston Pharmaceuticals, Inc. and a purchase agreement with Reata Pharmaceuticals Inc. For more information, visit the company's website at www.cnspharma.com.
Concierge Technologies Inc. (CNCG)
Concierge Technologies (OTCQB: CNCG), originally founded in 1996, was repositioned as a global holding firm in 2015, and currently has operating subsidiaries in financial services, food manufacturing, security systems and beauty products. The company invests in, and builds, great companies by working to identify and acquire established, profitable, undervalued companies in diverse sectors, then manage the portfolio to facilitate growth and add value for all stakeholders. Offices and manufacturing operations are in the U.S., New Zealand and Canada. For more information, visit the company's website at www.conciergetechnology.net.
Consumer Portfolio Services Inc. (CPSS)
Consumer Portfolio Services (NASDAQ: CPSS) is an independent specialty finance company that provides indirect automobile financing to individuals with past credit problems, low incomes, or limited credit histories. The company purchases retail installment sales contracts primarily from franchised automobile dealerships secured by late model used vehicles and, to a lesser extent, new vehicles. Consumer Portfolio Services funds these contract purchases on a long-term basis primarily through the securitization markets and service the contracts over their lives. For more information, visit the company's website at www.consumerportfolio.com.
Converge Technology Solutions Corp. (CTSDF)
Converge Technology Solutions (OTCQX: CTSDF) combines innovation accelerators and foundational infrastructure solutions to deliver best-of-breed solutions and services to customers. The company is building a platform of regionally-focused Hybrid IT solution providers to enhance their ability to provide multi-cloud solutions, blockchain, resiliency, and managed services, enabling Converge to address the business and IT issues that public and private-sector organizations face today. For more information, visit the company's website at www.convergetp.com.
Crexendo Inc. (CXDO)
Crexendo (OTCQX: CXDO) is a full-service cloud communications provider that delivers critical voice and data communication services to small, medium, and small enterprise markets. Crexendo is comprised of industry-leading engineering, sales, marketing and support professionals that design, sell, service, and support the company's award winning, patented technology that enhances business productivity and efficiency at reduced costs. Crexendo is PCI and HIPPA compliant, and a registered CLEC licensed for its cloud, telecommunications and network suite of services. For more information, visit the company's website at www.crexendo.com.
CV Sciences Inc. (CVSI)
CV Sciences (OTCQB: CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics utilizing CBD. CV Sciences' state-of-the-art facility follows all guidelines for Good Manufacturing Practices (GMP) and the company's full spectrum hemp extracts are processed, produced, and tested throughout the manufacturing process to confirm the cannabinoid content meets strict company standards. For more information, visit the company's website at www.cvsciences.com.
Data I/O Corp. (DAIO)
Data I/O (NASDAQ: DAIO) is among the world's leading global providers of advanced data and security programming solutions for flash, flash-memory based intelligent devices and microcontrollers. Since 1972, Data I/O has developed innovative solutions to enable the design and manufacture of electronic products for automotive, Internet-of-Things, medical, wireless, consumer electronics, industrial controls and other markets. Today customers use Data I/O's security provisioning and programming solution to reliably, securely and cost-effectively bring innovative new products to life. For more information, visit the company's website at www.dataio.com.
Delcath Systems Inc. (DCTH)
Delcath Systems (OTCQB: DCTH) is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Decalth' s investigational product – Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) – is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Melphalan/HDS has not been approved by the U.S. Food & Drug Administration (FDA) for sale in the U.S. In Europe, its system has been commercially available since 2012 under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT), where it has been used at major medical centers to treat a wide range of cancers of the liver. For more information, visit the company's website at www.delcath.com.
DelMar Pharmaceuticals Inc. (DMPI)
DelMar Pharmaceuticals (NASDAQ: DMPI) is a biopharmaceutical company focused on the development and commercialization of new cancer therapies. The company's lead product candidate, VAL-083, is a "first-in-class" small molecule DNA-targeting agent that is currently being evaluated in a biomarker-driven, Phase 2 clinical trial for the treatment of Unmethylated MGMT recurrent glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. The company is also exploring VAL-083 in a Phase 2 trial as a therapy for front-line Unmethylated MGMT GBM and we may study other solid tumors, including ovarian cancer and pediatric CNS tumors. For more information, visit the company's website at www.delmarpharma.com.
Deveron UAS Corp. (CSE: DVR)
Deveron UAS Corp. (CSE: DVR) is an agriculture technology company focused on data acquisition and analysis that helps farmers reduce costs and increase yields. The company has positioned itself for exponential growth in the North American market through partnerships with Fortune 500 companies and analytics software that help take the guesswork out of farming. Deveron emphasizes transparency and a focus on building shareholder value. For more information, visit the company's website at www.deveronuas.com.
DHI Group, Inc. (DHX)
DHI Group (NYSE: DHX) is the parent company of Dice.com, ClearanceJobs.com and eFinancialCareers. The company is a leading provider of career marketplaces connecting technology talent with employers. DHI Group's mission is to empower professionals and organizations to compete and win through specialized insights and relevant connections. For nearly 30 years, the company has grown by providing employers and recruiters with efficient access to high quality, unique technology professionals, and through offering technology professionals access to highly relevant career opportunities, news, tools and information. Today, DHI Group serves multiple markets primarily located throughout North America, Europe and the Asia Pacific region. For more information, visit the company's website at www.dhigroupinc.com.
Digital Ally Inc. (DGLY)
Digital Ally (NASDAQ: DGLY) was created to develop and manufacture technology that provides customers with the ultimate liability protection and evidence recording capabilities, coupled with convenience and ease of use. Established in 2004, Digital Ally Inc. adopted a think tank approach, utilizing multi-disciplined engineers, sales and support staff, as well as collaborating with cutting-edge firms to design innovative products. Digital Ally Inc.'s products have been developed for applications in industries such as law enforcement, fire, EMS, and commercial fleet management. Digital Ally has also developed a dynamic, comprehensible back office software solution for easy management, review, and archiving of recorded evidence. For more information, visit the company's website at www.digitalallyinc.com.
Document Security Systems Inc. (DSS)
For over 16 years, Document Security Systems (NYSE: DSS) has protected corporations, financial institutions and governments from sophisticated and costly fraud. DSS' innovative anti-counterfeit, authentication and brand protection solutions are deployed to prevent attacks which threaten products, digital presence, financial instruments and identification. AuthentiGuard®, the company's flagship product, provides authentication capability through a smartphone application so businesses can empower a wide range of employees, supply chain personnel, and consumers to track brands and verify authenticity. For more information, visit the company's website at www.dsssecure.com.
Dolphin Entertainment Inc. (DLPN)
Dolphin Entertainment (NASDAQ: DLPN) is an independent entertainment marketing and premium content development company. Through its subsidiaries, 42West and The Door, the company provides expert strategic marketing and publicity services to many of the top brands, both individual and corporate, in the entertainment and hospitality industries. Dolphin's recent acquisition of Viewpoint Creative adds full-service creative branding and production capabilities to the company's marketing group. Dolphin's legacy content production business, founded by Emmy-nominated CEO Bill O'Dowd, has produced multiple feature films and award-winning digital series. For more information, visit the company's website at www.dolphinentertainment.com.
DPW Holdings Inc. (DPW)
DPW Holdings, Inc (NYSE: DPW) is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies that hold global potential. Through its wholly owned subsidiaries and strategic investments, the company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, crypto-mining, and textiles. In addition, the company owns a select portfolio of commercial hospitality properties and extends credit to select entrepreneurial businesses through a licensed lending subsidiary. For more information, visit the company's website at www.DPWHoldings.com.
Duos Technologies Group Inc. (DUOT)
Duos Technologies Group (OTCQX: DUOT), through its wholly owned subsidiary, Duos Technologies Inc., provides intelligent, advanced technology solutions with a strong portfolio of intellectual property. The company's core competencies include intelligent technologies that combine machine learning, artificial intelligence and advanced video analytics that are delivered through its proprietary integrated enterprise command and control centraco® platform. The company provides a broad range of technology solutions with an emphasis on mission critical security, inspection and operations within the rail transportation, retail, petrochemical, government and banking sectors. Duos Technologies also offers professional and consulting services for large data centers. For more information, visit the company's website at www.duostech.com.
Dyadic International Inc. (DYAI)
Dyadic International (NASDAQ: DYAI) is a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines, drugs, and other biologic products at flexible commercial scales. Dyadic pursues research and development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to create synergy by leveraging Dyadic's technologies in development and manufacture of biopharmaceuticals. In particular, as the aging population grows in developed and undeveloped countries, Dyadic believes the C1 technology may help bring biologic vaccines, drugs and other biologic products to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers, and as a result improve access and cost to patients and the healthcare system, and most importantly, save lives. For more information, visit the company's website at www.dyadic.com.
Dynatronics Corp. (DYNT)
Dynatronics (NASDAQ: DYNT) is a medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. Dynatronics designs, manufactures and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals and consumers. The company's products are marketed under a portfolio of high quality, well-known industry brands including Bird & Cronin®, Dynatron Solaris®, Hausmann™, Physician's Choice®, and PROTEAM™, among others. For more information, visit the company's website at www.dynatronics.com.
ElectraMeccanica Vehicles Corp. (SOLO)
ElectraMeccanica Vehicles (NASDAQ: SOLO) is a Canadian designer and manufacturer of electric vehicles. The company's flagship vehicle is the innovative, purpose built, single seat electric vehicle called the SOLO. This vehicle will revolutionize commuting, delivery and shared mobility. The SOLO provides a driving experience that is unique, trendy, fun, affordable and environmentally friendly. InterMeccanica, a subsidiary of ElectraMeccanica, has successfully been building high-end specialty cars for 60 years. For more information, visit the company's website at www.electrameccanica.com.
electroCore Inc. (ECOR)
electroCore (NASDAQ: ECOR) is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company's current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache. For more information, visit the company's website at www.electrocore.com.
eMagin Corporation (EMAN)
eMagin (NYSE: EMAN) manufactures high-resolution OLED microdisplays and integrates them with magnifying optics to deliver virtual images comparable to large-screen computer and television displays in portable, low-power, lightweight personal displays. eMagin's microdisplays provide near-eye imagery in a variety of products for military, industrial, medical and consumer applications. For more information, visit the company's website at www.emagin.com.
Emerald Bioscience Inc. (EMBI)
Emerald Bioscience (OTCQB: EMBI) is focused on the discovery, development and commercialization of bioengineered cannabinoid-based therapeutics for significant unmet medical needs in global markets. With proprietary technology licensed from the University of Mississippi, Emerald is developing novel ways to deliver cannabinoid-based drugs for specific indications with the aim of optimizing the clinical effects of such drugs while limiting potential adverse events. Emerald Bioscience is part of the Emerald Group, which comprises multiple companies focused on developing pharmaceutical, botanical and nutraceutical products providing wellness and medical benefits by interacting with the human body's endocannabinoid system. For more information, visit the company's website at www.emeraldbio.life.
Emerald Health Therapeutics (TSXV: EMH) (OTCQX: EMHTF), a Canadian licensed producer under the Cannabis Act, produces and sells dried cannabis and cannabis oil for medical and recreational purposes. A vertically integrated, seed-to-sale enterprise, Emerald has combined core competencies from decades of experience in pharmaceutical innovation with large scale agriculture expertise focused on developing value-added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group, which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body's endocannabinoid system. For more information, visit the company's website at www.emeraldhealth.ca/en.
Enservco Corp. (ENSV)
Enservco (NYSE: ENSV) is a diversified national provider of specialized well-site services to the domestic onshore conventional and unconventional oil and gas industries. Through its various operating subsidiaries, Enservco provides a wide range of oilfield services including hot oiling, acidizing, frac water heating, water transfer and related services. The company has a broad geographic footprint covering seven major domestic oil and gas basins and serves customers in Colorado, Montana, New Mexico, North Dakota, Oklahoma, Pennsylvania, Ohio, Texas, Wyoming and West Virginia. For more information, visit the company's website at www.enservco.com.
Enthusiast Gaming Holdings Inc. (EGLX)
Enthusiast Gaming (TSX.V: EGLX) (FSE: 2AV) is building the world's largest network of communities for gamers and esports fans. The company's business is comprised of three main pillars: media, events and esports. The media network generates over 30 billion ad requests and over 1 billion page views per month. Enthusiast's esports division, Luminosity Gaming, is a global esports franchise that consists of seven professional esports teams under ownership and management, including the Vancouver Titans Overwatch team and the Seattle-based Call of Duty team. Collectively, the integrated ecosystem reaches over 200 million gaming enthusiasts on a monthly basis. For more information, visit the company's website at www.enthusiastgaming.com.
Envision Solar International Inc. (EVSI)
Envision Solar International (NASDAQ: EVSI) is a producer of unique and patented, sustainable infrastructure products for electric vehicle charging, energy security and outdoor media. Products include the EV ARC™ and the Solar Tree® with EnvisionTrak™ patented solar tracking, SunCharge™ solar Electric Vehicle Charging, ARC™ technology energy storage, and EnvisionMedia™ solar advertising displays. Based in San Diego, the company produces Made in America products. Envision Solar is listed on the Nasdaq CM under the symbols EVSI and EVSIW. For more information, visit the company's website at www.envisionsolar.com.
Exactus Inc. (EXDI)
Exactus (OTCQB: EXDI) is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is also engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less (THC is the psychoactive compound found in cannabis). For more information, visit the company's website at www.exactusinc.com.
Exro Technologies (CNSX: XRO) (OTCQB: EXROF) is a Vancouver, British Columbia-based technology company that is dedicated to creating an intelligent energy management system that converts energy in new ways to improve the performance, efficiency, and longevity of batteries, electric motors, and generators. Exro's foundational Dynamic Power Management System (DPM) improves the performance and efficiency of electric motors by separating individual coils to thereby enable coil switching according to power needs. Exro also applies its novel approach to generators by isolating the individual coils and applying DPM to the system, thereby allowing for a greater range of energy creation. For more information, visit the company's website at www.exro.com.